Olivier Bohuon became CEO of Smith & Nephew in April 2011 and plans to retire at the end of 2018.
Spinal Tech
CEOs of medical device company giants routinely make seven-figure salaries, with total compensation reaching even higher when bonuses and stock awards are included.
Stryker ranks No. 16 out of 100 on Fortune Magazine's Best Companies to Work For list. Here are four insights:
The global artificial disc replacement market is set to grow at a 15 percent compound annual growth rate through 2023, based on a Market Research Future report, according to Herald Keeper.
Mazor CEO Ori Hadomi spoke on several topics during the 2017 earnings call earlier this week, including the future for both the Renaissance and Mazor X systems, according to a transcript published in Seeking Alpha. He also touched on the…
Advertisement
Simplify Medical concluded enrollment for its U.S. investigational device exemption trial testing the Simplify cervical artificial disc.
Enrollment is completed for Spineology's SCOUT clinical trial.
After crossing the 95 percent threshold in Vexim, Stryker plans to file a public buy-out offer followed by a squeeze-out for outstanding Vexim shares.
Here are 16 key notes on orthopedic and spine device companies from the past week.
Mazor Robotics reported full year 2017 revenue at $64.9 million, including its investment from Medtronic for Mazor X systems. Mazor has now invested around $72 million in Mazor and taken over marketing efforts for the product; the companies will develop…